Covestor »

Janux Therapeutics shares owned by Covestor

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Covestor from 13F filings

Historical chart of Covestor investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Covestor consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Covestor

Quarter filed Position value Share count Share price at filing
2024-09-30 $0 3 0.00
2024-06-30 $0 3 0.00

More positions owned by Covestor

Nvidia Corp Common (NVDA)
Vanguard Total Stock Mkt Etf Etf (VTI)
Vanguard Ftse Developed Etf Etf (VEA)
Microsoft Corp Common (MSFT)
St Joe Co/the Common (JOE)
Meta Platforms Inc-class A Class A (META)
Spdr Bloomberg 1-3 Month T-b Etf (BIL)
Vanguard Ftse Emerging Marke Etf (VWO)
Amazon.com Common (AMZN)
Direxion Dly S&p 500 Bull 3x Etf (SPXL)
Vanguard High Dvd Yield Etf Etf (VYM)
Kyndryl Holdings Common (KD)
Berkshire Hathaway Inc-cl B Common (BRK.B)
Core Scientific Common (CORZ)
Servicenow Common (NOW)

View all positions for Covestor

Top funds holding Janux Therapeutics

RA Capital Management
BlackRock
Paradigm Biocapital Advisors
BlackRock
Henderson Group
Woodline Partners
Vanguard Group
EcoR1 Capital
State Street Corporation
OrbiMed Advisors
Citadel Advisors
Cormorant Asset Management
Logos Global Management
Lord, Abbett & Co
Geode Capital Management

View all funds holding Janux Therapeutics